Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>

ABSTRACT The chronic nature of tuberculosis (TB), its requirement of long duration of treatment, its ability to evade immune intervention, and its propensity to relapse after drug treatment is discontinued are reminiscent of other chronic, biofilm-associated bacterial diseases. Historically, Mycobac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dhinakaran Sambandan, Dee N. Dao, Brian C. Weinrick, Catherine Vilchèze, Sudagar S. Gurcha, Anil Ojha, Laurent Kremer, Gurdyal S. Besra, Graham F. Hatfull, William R. Jacobs
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2013
Materias:
Acceso en línea:https://doaj.org/article/0e4ca69911e645169334c63c251a3526
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0e4ca69911e645169334c63c251a3526
record_format dspace
spelling oai:doaj.org-article:0e4ca69911e645169334c63c251a35262021-11-15T15:40:05ZKeto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>10.1128/mBio.00222-132150-7511https://doaj.org/article/0e4ca69911e645169334c63c251a35262013-07-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00222-13https://doaj.org/toc/2150-7511ABSTRACT The chronic nature of tuberculosis (TB), its requirement of long duration of treatment, its ability to evade immune intervention, and its propensity to relapse after drug treatment is discontinued are reminiscent of other chronic, biofilm-associated bacterial diseases. Historically, Mycobacterium tuberculosis was grown as a pellicle, a biofilm-like structure, at the liquid-air interface in a variety of synthetic media. Notably, the most widely administered human vaccine, BCG, is grown as a pellicle for vaccine production. However, the molecular requirements for this growth remain ill defined. Here, we demonstrate that keto-mycolic acids (keto-MA) are essential for pellicle growth, and mutants lacking in or depleted of this MA species are unable to form a pellicle. We investigated the role of the pellicle biofilm in the reduction of antibiotic sensitivity known as drug tolerance using the pellicle-defective ΔmmaA4 mutant strain. We discovered that the ΔmmaA4 mutant, which is both pellicle defective and highly sensitive to rifampicin (RIF) under planktonic growth, when incorporated within the wild-type pellicle biofilm, was protected from the bactericidal activity of RIF. The observation that growth within the M. tuberculosis pellicle biofilm can confer drug tolerance to a drug-hypersensitive strain suggests that identifying molecular requirements for pellicle growth could lead to development of novel interventions against mycobacterial infections. Our findings also suggest that a class of drugs that can disrupt M. tuberculosis biofilm formation, when used in conjunction with conventional antibiotics, has the potential to overcome drug tolerance. IMPORTANCE Two of the most important questions in tuberculosis (TB) research are (i) how does Mycobacterium tuberculosis persist in the human host for decades in the face of an active immune response and (ii) why does it take six months and four drugs to treat uncomplicated TB. Both these aspects of M. tuberculosis biology are reminiscent of infections caused by organisms capable of forming biofilms. M. tuberculosis is capable of growing as a biofilm-like structure called the pellicle. In this study, we demonstrate that a specific cell wall component, keto-mycolic acid, is essential for pellicle growth. We also demonstrate that a strain of M. tuberculosis that is both drug sensitive and pellicle defective exhibits commensal behavior and becomes drug tolerant by becoming part of a heterogeneous pellicle, a characteristic of multispecies biofilms. These observations could have important implications for identifying novel pathways for M. tuberculosis drug tolerance and the design of new modalities to rapidly treat TB.Dhinakaran SambandanDee N. DaoBrian C. WeinrickCatherine VilchèzeSudagar S. GurchaAnil OjhaLaurent KremerGurdyal S. BesraGraham F. HatfullWilliam R. JacobsAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 4, Iss 3 (2013)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Dhinakaran Sambandan
Dee N. Dao
Brian C. Weinrick
Catherine Vilchèze
Sudagar S. Gurcha
Anil Ojha
Laurent Kremer
Gurdyal S. Besra
Graham F. Hatfull
William R. Jacobs
Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
description ABSTRACT The chronic nature of tuberculosis (TB), its requirement of long duration of treatment, its ability to evade immune intervention, and its propensity to relapse after drug treatment is discontinued are reminiscent of other chronic, biofilm-associated bacterial diseases. Historically, Mycobacterium tuberculosis was grown as a pellicle, a biofilm-like structure, at the liquid-air interface in a variety of synthetic media. Notably, the most widely administered human vaccine, BCG, is grown as a pellicle for vaccine production. However, the molecular requirements for this growth remain ill defined. Here, we demonstrate that keto-mycolic acids (keto-MA) are essential for pellicle growth, and mutants lacking in or depleted of this MA species are unable to form a pellicle. We investigated the role of the pellicle biofilm in the reduction of antibiotic sensitivity known as drug tolerance using the pellicle-defective ΔmmaA4 mutant strain. We discovered that the ΔmmaA4 mutant, which is both pellicle defective and highly sensitive to rifampicin (RIF) under planktonic growth, when incorporated within the wild-type pellicle biofilm, was protected from the bactericidal activity of RIF. The observation that growth within the M. tuberculosis pellicle biofilm can confer drug tolerance to a drug-hypersensitive strain suggests that identifying molecular requirements for pellicle growth could lead to development of novel interventions against mycobacterial infections. Our findings also suggest that a class of drugs that can disrupt M. tuberculosis biofilm formation, when used in conjunction with conventional antibiotics, has the potential to overcome drug tolerance. IMPORTANCE Two of the most important questions in tuberculosis (TB) research are (i) how does Mycobacterium tuberculosis persist in the human host for decades in the face of an active immune response and (ii) why does it take six months and four drugs to treat uncomplicated TB. Both these aspects of M. tuberculosis biology are reminiscent of infections caused by organisms capable of forming biofilms. M. tuberculosis is capable of growing as a biofilm-like structure called the pellicle. In this study, we demonstrate that a specific cell wall component, keto-mycolic acid, is essential for pellicle growth. We also demonstrate that a strain of M. tuberculosis that is both drug sensitive and pellicle defective exhibits commensal behavior and becomes drug tolerant by becoming part of a heterogeneous pellicle, a characteristic of multispecies biofilms. These observations could have important implications for identifying novel pathways for M. tuberculosis drug tolerance and the design of new modalities to rapidly treat TB.
format article
author Dhinakaran Sambandan
Dee N. Dao
Brian C. Weinrick
Catherine Vilchèze
Sudagar S. Gurcha
Anil Ojha
Laurent Kremer
Gurdyal S. Besra
Graham F. Hatfull
William R. Jacobs
author_facet Dhinakaran Sambandan
Dee N. Dao
Brian C. Weinrick
Catherine Vilchèze
Sudagar S. Gurcha
Anil Ojha
Laurent Kremer
Gurdyal S. Besra
Graham F. Hatfull
William R. Jacobs
author_sort Dhinakaran Sambandan
title Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
title_short Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
title_full Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
title_fullStr Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
title_full_unstemmed Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
title_sort keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive <named-content content-type="genus-species">mycobacterium tuberculosis</named-content>
publisher American Society for Microbiology
publishDate 2013
url https://doaj.org/article/0e4ca69911e645169334c63c251a3526
work_keys_str_mv AT dhinakaransambandan ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT deendao ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT briancweinrick ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT catherinevilcheze ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT sudagarsgurcha ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT anilojha ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT laurentkremer ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT gurdyalsbesra ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT grahamfhatfull ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
AT williamrjacobs ketomycolicaciddependentpellicleformationconferstolerancetodrugsensitivenamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontent
_version_ 1718427747612622848